Profile data is unavailable for this security.
About the company
Hikal Limited is an India-based company, which is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities. The Pharmaceuticals segment produces active pharmaceutical ingredients. Its facilities are in Jigani, Bangalore and Panoli, Gujrat. The Crop protection segment produces pesticides and herbicides. Its facilities are in Taloja, Mahad, Maharashtra and Panoli, Gujarat. Its human health product categories include anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-viral, anti-inflammatory, analgesic and anti-parasitic. Its animal health product categories include anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone and NSAID. Its crop protection product categories include algaecide, biocide, fungicide, herbicide, insecticide and intermediate.
- Revenue in INR (TTM)18.03bn
- Net income in INR677.82m
- Incorporated1988
- Employees2.06k
- LocationHikal LtdGreat Eastern ChambersSector 11, CBD-BelapurNAVI MUMBAI 400614IndiaIND
- Phone+91 2 230973100
- Fax+91 2 227574277
- Websitehttps://www.hikal.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dishman Carbogen Amcis Ltd | 24.16bn | -2.48bn | 28.85bn | 1.13k | -- | -- | 167.04 | 1.19 | -15.81 | -15.81 | 154.06 | -- | -- | -- | -- | 21,344,260.00 | -- | -0.3986 | -- | -0.4888 | 79.30 | 73.83 | -10.27 | -1.54 | -- | -0.7216 | -- | -- | 8.41 | 4.91 | -414.93 | -- | -0.3175 | -- |
SMS Pharmaceuticals Ltd | 7.38bn | 569.64m | 29.32bn | 1.20k | 51.31 | -- | 32.95 | 3.97 | 6.75 | 6.75 | 87.48 | -- | -- | -- | -- | 6,168,549.00 | -- | 5.43 | -- | 7.33 | 30.12 | 33.30 | 7.69 | 7.87 | -- | 4.21 | -- | 6.17 | 35.86 | 8.81 | 805.82 | 4.47 | 8.41 | 9.86 |
Indoco Remedies Ltd | 18.22bn | 766.90m | 31.38bn | 5.93k | 41.28 | -- | 18.02 | 1.72 | 8.25 | 8.25 | 178.33 | -- | -- | -- | -- | 3,072,462.00 | -- | 6.88 | -- | 9.85 | 68.61 | 65.59 | 4.10 | 6.93 | -- | 2.95 | -- | 14.02 | 8.91 | 13.41 | -30.78 | -- | 34.54 | 37.97 |
Solara Active Pharma Sciences Ltd | 13.00bn | -5.61bn | 31.83bn | 2.16k | -- | -- | -- | 2.45 | -143.75 | -143.75 | 334.17 | -- | -- | -- | -- | 6,030,149.00 | -- | -2.44 | -- | -3.84 | 37.34 | 41.16 | -43.17 | -4.49 | -- | -1.57 | -- | -- | -10.73 | -1.45 | -2,458.12 | -- | -4.81 | -- |
Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 39.15bn | 1.23k | -- | 123.84 | -- | -- | -- | -- | -- | 12.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8228 | -- | 0.2681 | -- | 43.84 | -- | 77.37 | -- | -- | -- |
Gufic BioSciences Ltd | 8.14bn | 863.69m | 39.36bn | 1.45k | 45.13 | -- | 38.04 | 4.83 | 8.70 | 8.70 | 81.95 | -- | -- | -- | -- | 5,624,707.00 | -- | 11.46 | -- | 19.21 | 52.39 | 45.79 | 10.60 | 10.46 | -- | 8.09 | -- | 1.31 | 16.80 | 18.12 | 8.07 | 31.46 | 53.83 | 14.87 |
Innova Captab Ltd | 11.42bn | 1.06bn | 41.36bn | -- | 30.51 | -- | 33.29 | 3.62 | 23.69 | 23.69 | 236.62 | -- | -- | -- | -- | -- | -- | 10.82 | -- | 18.38 | 33.38 | 25.18 | 9.30 | 8.04 | -- | 8.89 | -- | -- | 16.72 | 24.90 | 38.84 | 36.55 | 104.14 | -- |
Hikal Ltd | 18.03bn | 677.82m | 41.87bn | 2.06k | 61.80 | -- | 22.10 | 2.32 | 5.49 | 5.49 | 145.97 | -- | -- | -- | -- | 8,749,879.00 | -- | 5.07 | -- | 7.51 | 53.06 | 46.78 | 3.76 | 5.86 | -- | 2.45 | -- | 12.19 | -11.79 | 2.34 | -11.20 | -7.55 | 9.72 | 0.00 |
RPG Life Sciences Limited | 6.00bn | 923.20m | 45.74bn | 1.27k | 49.54 | -- | 41.41 | 7.63 | 55.82 | 55.82 | 362.60 | -- | -- | -- | -- | 4,721,969.00 | -- | 16.07 | -- | 21.77 | 68.42 | 62.99 | 15.39 | 11.99 | -- | 220.43 | -- | 29.27 | 13.50 | 12.01 | 29.60 | 51.98 | 28.60 | 46.14 |
Aarti Drugs Ltd | 24.23bn | 1.57bn | 46.55bn | 1.06k | 29.86 | -- | 22.26 | 1.92 | 17.08 | 17.08 | 263.82 | -- | -- | -- | -- | 22,770,740.00 | -- | 9.73 | -- | 15.78 | 34.32 | 22.23 | 6.48 | 8.25 | -- | 7.28 | -- | -- | -6.90 | 10.13 | 3.07 | 13.82 | 24.96 | -- |
Unichem Laboratories Ltd | 17.28bn | -605.50m | 47.11bn | 3.19k | -- | -- | 90.17 | 2.73 | -8.59 | -8.59 | 245.15 | -- | -- | -- | -- | 5,410,587.00 | -- | -1.67 | -- | -2.03 | 62.00 | 56.18 | -3.50 | -3.99 | -- | 0.1401 | -- | -- | 26.94 | 7.64 | 65.15 | -- | -35.00 | -- |
Supriya Lifescience Ltd | 5.99bn | 1.35bn | 47.18bn | 448.00 | 34.90 | -- | 31.09 | 7.88 | 16.80 | 16.80 | 74.42 | -- | -- | -- | -- | 13,370,000.00 | -- | 19.08 | -- | 24.04 | 62.75 | 57.12 | 22.58 | 24.71 | -- | 92.47 | -- | 2.88 | 23.74 | 15.47 | 32.56 | 24.75 | 83.79 | -- |
SeQuent Scientific Ltd | 14.27bn | 54.87m | 48.19bn | 1.20k | 905.27 | -- | 62.04 | 3.38 | 0.2137 | 0.2137 | 57.18 | -- | -- | -- | -- | 11,939,190.00 | -- | 1.09 | -- | 1.76 | 45.38 | 41.97 | 0.9902 | 1.18 | -- | 0.9009 | -- | 35.06 | -3.60 | 5.68 | 70.40 | -- | 6.96 | -- |
Morepen Laboratories Ltd | 17.45bn | 1.18bn | 48.74bn | 1.62k | 38.49 | -- | 32.57 | 2.79 | 2.31 | 2.31 | 34.26 | -- | -- | -- | -- | 10,749,300.00 | -- | 7.90 | -- | 13.34 | 37.86 | 33.34 | 6.77 | 5.49 | -- | 33.34 | -- | 0.00 | 19.25 | 17.08 | 148.63 | 27.22 | 47.03 | -- |
Aarti Pharmalabs Ltd | 19.50bn | 2.25bn | 55.29bn | 1.63k | 24.54 | -- | 18.34 | 2.84 | 24.86 | 24.86 | 215.17 | -- | -- | -- | -- | 11,983,730.00 | -- | -- | -- | -- | 44.20 | -- | 11.55 | -- | -- | 18.55 | -- | -- | -4.76 | -- | 12.10 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Tata Asset Management Pvt Ltd.as of 31 Jul 2024 | 3.30m | 2.68% |
Norges Bank Investment Managementas of 30 Sep 2023 | 2.54m | 2.06% |
Th�l�me Partners LLPas of 30 Sep 2023 | 1.29m | 1.05% |
Dimensional Fund Advisors LPas of 04 Jul 2024 | 849.17k | 0.69% |
Fiduciary Management, Inc.as of 30 Jun 2024 | 216.19k | 0.18% |
BlackRock Advisors (UK) Ltd.as of 04 Jul 2024 | 145.31k | 0.12% |
BlackRock Fund Advisorsas of 03 Jul 2024 | 99.20k | 0.08% |
American Century Investment Management, Inc.as of 03 Jul 2024 | 88.08k | 0.07% |
Mellon Investments Corp.as of 03 Jul 2024 | 83.05k | 0.07% |
Motilal Oswal Asset Management Co. Ltd.as of 31 Jul 2024 | 68.99k | 0.06% |